Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-16 | New | $1,110,000 | $1,110,000 | Other | 06b | SEC link |
| 2024-12-31 | New | $3,183,997 | $3,183,997 | Other | 06b | SEC link |
| 2024-02-29 | New | $2,694,470 | $2,694,470 | Debt Only | 06b | SEC link |
| 2021-12-02 | Amended | $18,352,692 | $2,410,524 | Equity Only | 06b | SEC link |
| 2021-10-06 | Amended | $15,942,168 | $6,840,411 | Equity Only | 06b | SEC link |
| 2021-07-07 | New | $9,101,757 | $9,101,757 | Equity Only | SEC link | |
| 2020-09-17 | New | $1,131,000 | $1,131,000 | Debt Only | 06b | SEC link |
| 2017-07-27 | New | $8,024,611 | $8,024,611 | Equity Only | 06b | SEC link |
| 2017-02-21 | New | $1,040,000 | $1,040,000 | Equity Only | 06b | SEC link |
| 2016-11-16 | New | $490,000 | $490,000 | Equity Only | 06b | SEC link |
| 2016-04-06 | New | $535,000 | $535,000 | Debt Only | 06b | SEC link |
| 2015-05-06 | New | $850,000 | $850,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Eric Bell | Director |
| Mark Benjamin | Executive |
| Javier Castellanos | Executive |
| Nivon Lucas | Director, Executive, Promoter |
| Anthony Manning | Director |
| Lucas Nivon | Director, Executive |
| Ramakrishna Satyavolu | Director |
| Jason Smith | Director |
| Yifan Song | Director |
| Gus Tai | Director |
| Chad Waite | Director |